News Sentiment

IMRX sentiment intelligence

Immuneering Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 38 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 5.11 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 30

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.5% over one week, +22.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Immuneering (IMRX) Upgraded to Buy: Here's What You Should Know

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction -1.5% Price digesting
Trend fit Trend inactive 22.0% over four weeks
Fair value 19.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 29
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 30
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
simplywall.st 7
Stock Titan 6
GlobeNewswire 5
TradingView 2
MT Newswires 2
Quiver Quantitative 2
Quartr 1

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 12
Analyst action 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 38